Evaluating the utility of
ZNF331
promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance)
Epigenetics | May 8, 2024 | Volume: 19 | Issue: 1 | Pages: No page available
10.1080/15592294.2024.2349980
| PMID 38716804